Butane

Butane

SCHEMBL5208

CCCC.O=[PH](O)OCl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7649827 0.83
Butane SCHEMBL712996 0.78
Butane SCHEMBL27301811 0.78 ALDH1A1 (0.30)
Butane SCHEMBL11429688 0.76
Butane SCHEMBL10634592 0.76 TSHR (0.35)
Butane SCHEMBL8769360 0.76
Butane SCHEMBL472717 0.75 CES2 (0.35)
Butane SCHEMBL729837 0.75
Butane SCHEMBL11209036 0.75 CES2 (0.35)
Ethyl Hydrogen Phosphonate SCHEMBL26482 0.75 ALDH1A1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499146-B1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2016-09-21 EP disclosed
CN-102945800-B The rear deposition encapsulating of nanostructure: composition, device and comprise their system SANDISK CORP. (US) 2016-01-06 CN disclosed
US-9073940-B2 Tricyclic pyrazol amine derivatives MERCK SERONO SA (CH) 2015-07-07 US disclosed
CN-102054527-B Post-deposition encapsulation of nanostructures: compositions, devices and systems incorporating same SANDISK CORP 2014-03-26 CN disclosed
CN-1668288-B Compounds with antiparasitic activity and medicaments containing them CENTRE NAT RECH SCIENT 2013-07-17 CN disclosed
CN-102079729-B Compounds with antiparasitic activity and medicaments containing them CENTRE NAT RECH SCIENT 2013-04-24 CN disclosed
CN-102945800-A Post-deposition encapsulation of nanostructures: compositions, devices and systems incorporating same NANOSYS INC 2013-02-27 CN disclosed
CN-101426639-B Post-deposition encapsulation of nanostructures compositions, devices, and systems comprising the same NANOSYS INC 2012-11-14 CN disclosed
US-20120238545-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES MERCK SERONO SA (CH) 2012-09-20 US disclosed
EP-2499146-A1 TRICYCLIC PYRAZOL AMINE DERIVATIVES Merck Serono S.A. (CH) 2012-09-19 EP disclosed
CN-1599612-A Combination of FBP enzyme inhibitor and antidiabetic agent for treating diabetes METABASIS THERAPEUTICS INC (US) 2005-03-23 CN disclosed
EP-1220851-B1 CARBON DIOXIDE-PHILIC COMPOUNDS AND METHODS OF SYNTHESIS THEREOF UNIV PITTSBURGH (US) 2004-08-18 EP disclosed
US-20040158013-A1 Carbon dioxide-philic compounds and methods of synthesis thereof BECKMAN ERIC J (US) 2004-08-12 US disclosed
US-20040072865-A1 Aryl piperidine derivatives as inducers of ldl-receptor expression SMITHKLINE BEECHAM CORPORATION 2004-04-15 US disclosed
US-6686438-B1 REACTING THE CO2-PHOBIC COMPOUND WITH A CO2-PHILIC COMPOUND, WHEREIN THE CO2-PHILIC COMPOUND IS A POLYETHER SUBSTITUTED WITH AT LEAST ONE SIDE GROUP INCORPORATING A LEWIS BASE UNIVERSITY OF PITTSBURGH 2004-02-03 US disclosed
EP-1351935-A1 ARYL PIPERIDINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION GLAXO GROUP LIMITED (GB) 2003-10-15 EP disclosed
EP-1220851-A4 CARBON DIOXIDE-PHILIC COMPOUNDS AND METHODS OF SYNTHESIS THEREOF UNIV PITTSBURGH (US) 2003-01-08 EP disclosed
WO-2002055495-A1 ARYL PIPERIDINE DERIVATIVES AS INDUCERS OF LDL-RECEPTOR EXPRESSION GLAXO GROUP LIMITED (GB) 2002-07-18 WO disclosed
EP-1220851-A1 CARBON DIOXIDE-PHILIC COMPOUNDS AND METHODS OF SYNTHESIS THEREOF UNIVERSITY OF PITTSBURGH (US) 2002-07-10 EP disclosed
WO-2001021616-A1 CARBON DIOXIDE-PHILIC COMPOUNDS AND METHODS OF SYNTHESIS THEREOF UNIVERSITY OF PITTSBURGH (US) 2001-03-29 WO disclosed